Sectors

LTRN
Lantern Pharma Inc.
2.81
1 x 2.71
1 x 2.82
bid
ask
+
0.00
0.00%
09:37 AM
timesize
Ytd-7.26%
1y-35.10%
2.81
day range
2.87
1.11
52 week range
4.86
Open2.81Prev Close2.81Low2.81High2.87Mkt Cap35.85M
Vol2.85KAvg Vol208.61KEPS-1.45P/E-1.94Forward P/E-1.50
Beta2.34Short Ratio4.74Inst. Own24.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg3.38200-d Avg3.061yr Est20.50
Income Statement
Operating Expenses3.41M
Research and Development Expense1.72M
Selling, General and Administrative Expense1.68M
Operating Income-3.41M
Net Income-3.33M
Net Income Common Stock-3.33M
Net Income Common Stock (USD)-3.33M
Consolidated Income-3.33M
Earnings per Basic Share-0.30
Earnings per Basic Share (USD)-0.30
Earnings per Diluted Share-0.30
Earning Before Interest & Taxes (EBIT)-3.33M
Earning Before Interest & Taxes (USD)-3.33M
Weighted Average Shares11.25M
Weighted Average Shares Diluted11.25M
Balance Sheet
Cash and Equivalents4.92M
Cash and Equivalents (USD)4.92M
Investments1.41M
Investments Current1.41M
Current Assets7.06M
Property, Plant & Equipment Net84.89K
Total Assets7.22M
Debt Current59.08K
Total Debt59.08K
Current Liabilities3.78M
Total Liabilities3.78M
Accumulated Retained Earnings (Deficit)-96.47M
Accumulated Other Comprehensive Income-35.64K
Shareholders Equity3.45M
Shareholders Equity (USD)3.45M
Assets Non-Current165.81K
Total Debt (USD)59.08K
Trade and Non-Trade Payables3.72M
Cash Flow
Depreciation, Amortization & Accretion22.58K
Net Cash Flow / Change in Cash & Cash Equivalents494.96K
Net Cash Flow from Investing4.25M
Net Cash Flow - Investment Acquisitions and Disposals4.25M
Net Cash Flow from Operations-3.77M
Effect of Exchange Rate Changes on Cash 17.59K
Share Based Compensation262.92K